002424.SZ Stock Analysis
00
Avoid
Based on Eyestock quantitative analysis, 002424.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly undervalued
Guizhou Bailing Group Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicines. The company is headquartered in Anshun, Guizhou and currently employs 6,124 full-time employees. The company went IPO on 2010-06-03. The firm is also engaged in the provision of Chinese medicine materials. The firm is also engaged in the distribution of fertilizers and purified water, and the operation of medical institutions. The firm conducts its businesses mainly within domestic markets.